Search results for: 'polym pharmaceutical'

Traditionally, CMOs have thrived by aggregating demand and delivering benefits of economies of scale. However, with the fading era of blockbuster drugs dispensed to large patient pools and shift to precision medicine, focus on niche indications, and increased R&D in biologics, pharma sponsors are increasingly turning to CMOs as strategic partners i...

08 Apr 2026  |  Global  |  Market Research

Engineering Plastics, Global, 2025–2032

Engineering Plastics are Experiencing Transformational Growth Due to Innovation, Regulation, and Advanced Applications

Infographics

×

This study presents a comprehensive analysis of the global engineering plastics market, evaluating industry dynamics, demand scenarios, and strategic growth opportunities across the value chain. The analysis covers key engineering polymer families, including polycarbonate (PC), polyamides (PA), polyoxymethylene (POM), polyesters (PBT and injection-...

The research service aims to analyse and assess the global generics pharmaceutical market, map the key trends and dynamics shaping the industry sector and provide strategic recommendations for the success of the market participants. With several key blockbuster drugs losing patent protection and new healthcare reforms being introduced by the Govern...

The global small‑molecule CDMO industry is undergoing a structural transformation driven by increasing molecular complexity, patent expiries, cost pressures, and the strategic need to secure resilient pharmaceutical supply chains. Demand is shifting beyond high‑volume commodity generics toward specialized development and manufacturing capabilities ...

Pharmaceutical drug discovery and development suffers from declining success rates with new molecules, and the rate of return has shrunk from 16% in 2011 to almost 11% in 2018. Frost & Sullivan finds that traditional solutions focused primarily on data from limited sources and rule-based computational techniques used to address the understanding of...

20 Jun 2017  |  North America  |  Market Research

Transformation and Growth Opportunities in the US Next-Generation Sequencing Informatics Market

Pharmaceutical and Molecular Diagnostics Segments to Lead Revenue Growth

Infographics

×

Frost & Sullivan expects strong demand for commercial application-focused solutions to drive new investments in the development of tools and technologies, and will also result in consolidation of the US next-generation sequencing informatics market. Changing customer requirements and intense competition will drive the transformation. As companies l...

Pharmaceutical drug discovery and development suffers from declining success rates with new molecules and the rate of return shrinking from 16Percentage in 2011 to almost 11Percentage in 2018. Frost & Sullivan research indicates that traditional solutions that have focused primarily on data from limited sources and rule-based computational techniqu...

Ever-evolving consumer preferences, growing urbanization and rising disposable incomes, rapid technological advancements, and the proliferation of affordable Internet connectivity, among other factors collectively entails a dynamic period for the global consumer electronics market, composed primarily of devices such as televisions, computing device...